Intrasplenic implantation of tissue-engineered pancreatic construct in experimental diabetic rats
https://doi.org/10.15825/1995-1191-2020-1-134-141
Abstract
Objective: to study the effect of intrasplenic implantation of a tissue-engineered pancreatic construct (TEPC) on experimental diabetes mellitus. Materials and methods. Floating islet-like cultures (FICs) were obtained from the pancreas of newborn rabbits. To form TEPC, FICs were incubated with biopolymer microheterogeneous collagen-containing hydrogel (BMCH). TEPC samples were injected into the splenic pulp of rats with streptozotocin-induced diabetes. Results. TEPC with insulin-producing activity was formed on the 7–10th day of incubation of FICs with BMCH. After TEPC implantation in recipient rats, persistent decrease in hyperglycemia and disappearance of clinical signs of diabetes were noted. Histological analysis revealed the presence of groups of islet cells without signs of immune cell response at the TEPC implantation site. Conclusion. Our findings indicate that xenogeneic islet cells that were part of the TEPC of the pancreas can survive and actively function after implantation in the splenic pulp of diabetic rat.
About the Authors
G. N. Skaletskaya
Shumakov National Medical Research Center of Transplantology and Artificial Organs
Russian Federation
Russian Federation
Skaletskaya Galina Nikolaevna.
1, Shchukinskaya str., Moscow, 123182
N. N. Skaletskiy
Shumakov National Medical Research Center of Transplantology and Artificial Organs
Russian Federation
Moscow
Russian Federation
Moscow
L. A. Kirsanova
Shumakov National Medical Research Center of Transplantology and Artificial Organs
Russian Federation
Moscow
Russian Federation
Moscow
G. N. Bubentsova
Shumakov National Medical Research Center of Transplantology and Artificial Organs
Russian Federation
Moscow
Russian Federation
Moscow
V. I. Sevastianov
Shumakov National Medical Research Center of Transplantology and Artificial Organs
Russian Federation
Moscow
Russian Federation
Moscow
References
1. Van Belle TL, Coppieters KT, von Herrath MG. Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev. 2011: 79–118. doi: 10.1152/physrev.00003.2010.
2. Lind M, Svensson A-M, Kosiborod M. Glycemic control and excess mortality in type 1 diabetes. N Engl J Med 371: 1972–1982. doi: 10.1056/NEJMoa1408214.
3. Pellegrini S, Cantarelli E, Sordi V, Nano R, Piemonti L. The state of the art of islet transplantation and cell therapy in type 1 diabetes. Acta Diabetol. 2016: 683–691. doi: 10.1007/s00592-016-0847-z.
4. Skaletskaya GN, Sevastianov VI. Eksperimentalnaya model tkaneinzhenernoy konstruktsii podzheludochnoy zhelezy. Transplantologia: itogi i perspektivy. Tom IX. 2017 god / Pod red. S.V. Gautier. M.–Tver’: Triada. 2018: 283–299.
5. Sevastianov VI, Perova NV. Inyektsionniy geterogenniy biopolimerniy gidrogel dla zamestitelnoy regenerativnoy khirurgii i sposoby ego polucheniya. Patent RF 2433828 (2010).
6. Sevastianov VI, Shagidulin MYu, Skaletskiy NN, Perova NV, Dovzhik IA, Gautier SV. Doklinicheskiye issledovaniya bezopasnosti i effektivnosti BMKP dla regeneratsii sustavnogo khrashcha, pecheni i podzheludochnoy zhelezy. Metodicheskiye rekomendatsii po provedeniyu doklinicheskikh issledovaniy biomeditsinskykh kletochnykh produktov / Pod red. akad. V.A. Tkachuka. M.: MGU, 2017: 187–255.
7. Bogdanova NB, Abramov VYu, Skaletskiy NN, Petrova IA, Pushkova IA, Bubentsova GN. Issledovanie fiksatsii syvorotochnykh immunoglobulinov cheloveka na kultivirovannykh ostrovkovykh kletkah podzheludochnoy zhelezy. IV Vserossiyskiy s’yezd transplantologov. M., 2008: 227–228.
Review
For citations:
Skaletskaya G.N., Skaletskiy N.N., Kirsanova L.A., Bubentsova G.N., Sevastianov V.I. Intrasplenic implantation of tissue-engineered pancreatic construct in experimental diabetic rats. Russian Journal of Transplantology and Artificial Organs. 2020;22(1):134-141. https://doi.org/10.15825/1995-1191-2020-1-134-141
Views:
766
Email this article 